Havix Group, founded in 2015 and headquartered in Hoschton, Georgia, is a pharmaceutical company specializing in contract development and manufacturing (CDMO). Operating in stealth mode, Havix Group focuses on the development and production of high-quality generic pharmaceuticals. The company's core mission is to advance drug development through proficient research and a commitment to quality, aiming to provide reliable and effective pharmaceutical solutions to the market.
Notable for its USFDA approval, Havix Group has established itself as one of the fastest-growing pharmaceutical companies in the Atlanta region. The company collaborates with various partners to enhance its capabilities in drug development and manufacturing. Despite its relatively recent inception, Havix Group's impact on the pharmaceutical industry is significant, contributing to the availability of high-quality generic medications and fostering innovation within the sector.